All Stories

  1. Measurement of carotid plaque burden
  2. Cost‐Utility Analysis of Low‐Dose Pioglitazone in a Population With Prediabetes and a History of Stroke or Transient Ischemic Attack
  3. Letter to the Editor From Spence: [Prevalence and Characteristics of Low-Renin Hypertension in a Primary Care Population]
  4. Homocysteine and Myocardial Injury
  5. Correspondence on: “Subclinical atherosclerosis: More data – More insights into prevention”
  6. Reducing Cardiovascular Risk: The Potential of Plant-Based Meat Alternatives and Egg Substitutes
  7. Poor Results with “Best Medical Therapy” in Patients with Asymptomatic Carotid Stenosis
  8. Vessel Wall Volume and Plaque Volume Should Replace Carotid Intima–Media Thickness
  9. Prior-knowledge Embedded U-Net based Fully Automatic Vessel Wall Volume Measurement of the Carotid Artery in 3D Ultrasound Image
  10. Carotid Plaque Burden Is a Stronger Predictor of Cardiovascular Risk Than IMT
  11. Vertebrobasilar ischemia: Some less recognized aspects
  12. Cerebrovascular Disease, Cardiovascular Disease, and Chronic Kidney Disease: Interplays and Influences
  13. Homocysteine and Thrombophilia in Pulmonary Hypertension
  14. Cardiovascular effects of TMAO and other toxic metabolites of the intestinal microbiome
  15. Acetaminophen, Nonsteroidal Anti-Inflammatory Drugs, and Hypertension
  16. In Memoriam: Jim Toole, MD: Ahead of His Time
  17. B vitamins for NASH: use methylcobalamin, not cyanocobalamin
  18. Problem in the Recent American Heart Association Guideline on Secondary Stroke Prevention: B Vitamins to Lower Homocysteine Do Prevent Stroke
  19. Identifying High-Risk Nonstenotic Carotid Artery Disease
  20. Management of Patients with Embolic Stroke of Unknown Source: Interpreting the Evidence in the Light of Clinical Judgement
  21. Efficacy of Lower Doses of Pioglitazone after Stroke or Transient Ischemic Attack In Patients with Insulin Resistance
  22. Fasting lipids are not a good way to assess the effects of diet on cardiovascular risk
  23. How to identify which patients should not have a systolic blood pressure target of <120 mmHg
  24. Deep Learning-Based Measurement of Total Plaque Area in B-Mode Ultrasound Images
  25. Roadmap Consensus on Carotid Artery Plaque Imaging and Impact on Therapy Strategies and Guidelines: An International, Multispecialty, Expert Review and Position Statement
  26. CONNed in Pregnancy
  27. Physiological Treatment of Hypertension in Black Patients: Time for Action
  28. Sex differences in the intestinal microbiome: interactions with risk factors for atherosclerosis and cardiovascular disease
  29. Triglyceride/High‐Density Lipoprotein Cholesterol Ratio: A Clue to Metabolic Syndrome, Insulin Resistance, and Severe Atherosclerosis
  30. Renovascular Hypertension
  31. Cardiovascular Harm From Egg Yolk and Meat: More Than Just Cholesterol and Saturated Fat
  32. It's time to stop the nonsense of withholding lipid lowering therapy on account of age
  33. Measurement of carotid plaque burden: A tool for predicting and preventing dementia?
  34. Stroke Prevention: Little-Known and Neglected Aspects
  35. Reducing the Risk of Stroke in Patients with Impaired Renal Function: Nutritional Issues
  36. Stroke Prevention in Older Adults
  37. A Voxel-Based Fully Convolution Network and Continuous Max-Flow for Carotid Vessel-Wall-Volume Segmentation From 3D Ultrasound Images
  38. IMT is not atherosclerosis
  39. China Stroke Statistics 2019: a wealth of opportunities for stroke prevention
  40. Recent advances in preventing recurrent stroke
  41. New Canadian guideline is wrong to say acetylsalicylic acid is only for patients with symptomatic vascular disease
  42. Achieving blood pressure control targets in hypertensive patients of rural China – a pilot randomized trial
  43. Risk from low blood pressure in frail older adults: diastolic pressure and pulse pressure are important
  44. Stroke Prevention
  45. Interaction of smoking, hyperhomocysteinemia and metabolic syndrome with carotid atherosclerosis: A cross sectional study in 972 non-diabetic patients
  46. Traffic‐Related Air Pollution and Carotid Plaque Burden in a Canadian City With Low‐Level Ambient Pollution
  47. Impaired Renal Function and Cerebrovascular Disease
  48. Triglyceride lowering drugs: not just icosapent ethyl
  49. Adding Insight to Injury!
  50. Effect of Vitamin B12 Levels on the Association Between Folic Acid Treatment and CKD Progression: A Post Hoc Analysis of a Folic Acid Interventional Trial
  51. Lower risk of stroke with a vegetarian diet
  52. Choosing the right therapy for a patient with asymptomatic carotid stenosis
  53. Patent foramen ovale in patients with atrial fibrillation
  54. Three-dimensional ultrasound evaluation of the effects of pomegranate therapy on carotid plaque texture using locality preserving projection
  55. Interaction of serum vitamin B12 and folate with MTHFR genotypes on risk of ischemic stroke
  56. Rationale for screening selected patients for asymptomatic carotid artery stenosis
  57. Asymptomatic Carotid Stenosis: High Risk With Suboptimal Treatment
  58. Longitudinal assessment of carotid plaque texture in three-dimensional ultrasound images based on semi-supervised graph-based dimensionality reduction and feature selection
  59. Mechanisms of Stroke in COVID-19
  60. The need for clinical judgement in the application of evidence-based medicine
  61. Chili Pepper Consumption and Cardiovascular Mortality
  62. Resistant Hypertension
  63. Socioeconomic status and stroke incidence, prevalence, mortality, and worldwide burden: an ecological analysis from the Global Burden of Disease Study 2017
  64. Trimethylamine N-oxide: not just red meat—egg yolk and renal function are also important
  65. Carotid Intima–Media Thickness Versus Carotid Plaque Burden for Predicting Cardiovascular Risk
  66. Interpreting stimulated plasma renin and aldosterone to select physiologically individualized therapy for resistant hypertension: importance of the class of stimulating drugs
  67. Registration of amiloride in South Africa: Cutting the Gordian knot
  68. Statins for Primary Prevention of Cardiovascular Disease
  69. Deep learning‐based carotid media‐adventitia and lumen‐intima boundary segmentation from three‐dimensional ultrasound images
  70. Coronary calcium is not all we need: Carotid plaque burden measured by ultrasound is better
  71. Periprocedural events dominate outcomes of carotid stenting and endarterectomy
  72. Nutrition and Risk of Stroke
  73. The Importance of Blood Pressure Gradients in the Brain
  74. Antiplatelet Therapy in Ischemic Stroke and Transient Ischemic Attack
  75. Pioglitazone Therapy in Patients With Stroke and Prediabetes
  76. Blood Pressure Gradients in the Brain: Their Importance to Understanding Pathogenesis of Cerebral Small Vessel Disease
  77. Anticoagulation in patients with Embolic Stroke of Unknown Source
  78. Vitamin B12 deficiency and hyperhomocysteinaemia in outpatients with stroke or transient ischaemic attack: a cohort study at an academic medical centre
  79. Increased carotid plaque burden in patients with family medical history of premature cardiovascular events in the absence of classical risk factors
  80. Hypertension in Africa
  81. Decline in the Severity of Carotid Atherosclerosis and Associated Risk Factors From 2002 to 2014
  82. Harm With High Levels of Serum B12 in Elderly Persons
  83. Cardiovascular benefit of egg consumption is most unlikely
  84. Advances in Stroke Prevention
  85. Elevated level of lecithin:cholesterol acyltransferase (LCAT) is associated with reduced coronary atheroma burden
  86. Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial
  87. Data on the gut and saliva microbiota from a cohort of atherosclerosis patients determined by 16S rRNA gene sequencing
  88. Moderate Renal Impairment and Toxic Metabolites Produced by the Intestinal Microbiome: Dietary Implications
  89. Hypertension in Blacks
  90. Fractal dimension based carotid plaque characterization from three-dimensional ultrasound images
  91. Mediterranean Diet Score: Associations with Metabolic Products of the Intestinal Microbiome, Carotid Plaque Burden, and Renal Function
  92. Stroke Prevention: Editorial to accompany June issue of SVN
  93. [18F]-Fluorodeoxyglucose PET/CT imaging as a marker of carotid plaque inflammation: Comparison to immunohistology and relationship to acuity of events
  94. Egg Consumption and Cardiovascular Risk
  95. Supplemental Vitamins and Minerals for CVD Prevention and Treatment
  96. Metabolic products of the intestinal microbiome and extremes of atherosclerosis
  97. Diastolic J curve, cuff artefact and low targets for SBP
  98. Problems with polypills
  99. The Spectrum of Subclinical Primary Aldosteronism and Incident Hypertension
  100. B Vitamins for Stroke Prevention
  101. Accuracy of Cardiovascular Risk Prediction Varies by Neighborhood Socioeconomic Position
  102. Cardioembolic stroke: everything has changed
  103. Controlling resistant hypertension
  104. How to identify which patients with asymptomatic carotid stenosis could benefit from endarterectomy or stenting
  105. Effect of wine on carotid atherosclerosis in type 2 diabetes: a 2-year randomized controlled trial
  106. Diet for stroke prevention
  107. Letter by Spence Regarding Article, “Serum Potassium Is Positively Associated With Stroke and Mortality in the Large, Population-Based Malmö Preventive Project Cohort”
  108. Homocysteine Lowering with B Vitamins for Stroke Prevention—A History
  109. Hypertension in US-born vs. foreign-born African-Americans
  110. Association of homocysteine and smoking with cerebral microemboli in patients with mechanical heart valves: a transcranial Doppler study
  111. Letter by Spence Regarding Article, “Antiplatelet Regimen for Patients With Breakthrough Strokes While on Aspirin: A Systematic Review and Meta-Analysis”
  112. Systolic blood pressure targets, diastolic J curve and cuff artefact in blood pressure measurement: a note of caution
  113. Patent Foramen Ovale Closure or Antiplatelet Therapy for Cryptogenic Stroke
  114. Smoking cessation and outcome after ischemic stroke or TIA
  115. B vitamins in stroke prevention: time to reconsider
  116. Sensitive three-dimensional ultrasound assessment of carotid atherosclerosis by weighted average of local vessel wall and plaque thickness change
  117. Motor recovery beginning 23 years after ischemic stroke
  118. Cuff Artifact, J Curve, and Application of Hypertension Guidelines in the Elderly
  119. Approaching Automated 3-Dimensional Measurement of Atherosclerotic Plaque Volume ∗
  120. Recent advances in preventing stroke recurrence
  121. Blood pressure gradients in cerebral arteries: a clue to pathogenesis of cerebral small vessel disease
  122. Nutrition in Stroke Prevention
  123. Resistant Atherosclerosis
  124. Physiological Phenotyping for Personalized Therapy of Uncontrolled Hypertension in Africa
  125. Rational Medical Therapy Is the Key to Effective Cardiovascular Disease Prevention
  126. Asymptomatic carotid stenosis
  127. Cardiovascular Efficacy and Safety of Bococizumab in High-Risk Patients
  128. [ 18 F]-NaF PET/CT Identifies Active Calcification in Carotid Plaque
  129. 3D Ultrasound for Imaging and Quantifying Carotid Ulcers
  130. Diastolic Hypotension and Myocardial Ischemia
  131. Transcranial Doppler monitoring for microemboli: a marker of a high-risk carotid plaque
  132. Carotid plaque burden is associated with higher levels of total homocysteine
  133. CADASIL accelerated by acute hypotension
  134. Hypertension in blacks
  135. High Frequency of Variants of Candidate Genes in Black Africans with Low Renin-Resistant Hypertension
  136. Effects of eplerenone on resistance to antihypertensive medication in patients with primary or secondary hyperaldosteronism
  137. Increased Coagulation With Aging: Importance of Homocysteine and Vitamin B12
  138. Henry J.M. Barnett
  139. Determinants of carotid plaque burden
  140. Folic acid supplementation and chronic kidney disease progression
  141. Re: ‘Transcranial Doppler Ultrasound Detection of Microemboli as a Predictor of Cerebral Events in Patients with Symptomatic and Asymptomatic Carotid Disease: A Systematic Review and Meta-Analysis’
  142. Intestinal Microbiome and Atherosclerosis
  143. Statins probably do not cause cataracts
  144. Folic Acid Therapy Reduces the First Stroke Risk Associated With Hypercholesterolemia Among Hypertensive Patients
  145. Editorial: Time for Earlier and More Intensive Preventive Therapy
  146. Latest Skirmishes in the Long-Term Battle Between Carotid Endarterectomy and Stenting
  147. Cryptogenic Stroke
  148. Taking care of volunteers in a stroke trial: a new assisted-management strategy
  149. Amiodarone, Lidocaine, or Placebo in Out-of-Hospital Cardiac Arrest
  150. Transcranial Doppler is Complementary to Echocardiography for Detection and Risk Stratification of Patent Foramen Ovale
  151. Homocysteine lowering for stroke prevention: Unravelling the complexity of the evidence
  152. Recent advances in pathogenesis, assessment, and treatment of atherosclerosis
  153. Transcranial Doppler Emboli Identifies Asymptomatic Carotid Patients at High Stroke Risk: Why This Technique Should be Used More Widely
  154. Strategies for improving blood pressure control in Africa
  155. Appropriate management of asymptomatic carotid stenosis
  156. Endarterectomy vs. stenting vs. medical therapy
  157. Pioglitazone after Ischemic Stroke or Transient Ischemic Attack
  158. Endarterectomy, Stenting, or Neither for Asymptomatic Carotid-Artery Stenosis
  159. Metabolic vitamin B12 deficiency: a missed opportunity to prevent dementia and stroke
  160. Plaque Assessment in the Management of Patients with Asymptomatic Carotid Stenosis
  161. Three-Dimensional Ultrasound of Carotid Plaque
  162. Overcoming Challenges With Statin Therapy
  163. Dietary cholesterol and egg yolk should be avoided by patients at risk of vascular disease
  164. Adding carotid total plaque area to the Framingham risk score improves cardiovascular risk classification
  165. Hypertension and Stroke
  166. Definition of Best Medical Treatment in Asymptomatic and Symptomatic Carotid Artery Stenosis
  167. Management of Patients with an Asymptomatic Carotid Stenosis—Medical Management, Endovascular Treatment, or Carotid Endarterectomy?
  168. Transcranial Doppler: Uses in Stroke Prevention
  169. Effect of renal impairment on atherosclerosis: only partially mediated by homocysteine
  170. J Curve and Cuff Artefact, and Diagnostic Inertia in Resistant Hypertension
  171. Risk of Stroke at the Time of Carotid Occlusion
  172. Review and prioritization of stroke research recommendations to address the mission of the World Stroke Organization: a call to action from the WSO Research Committee
  173. Carotid Ultrasound Phenotypes Are Biologically Distinct
  174. Letter by Spence Regarding Article, “Diet and Stroke: Recent Evidence Supporting a Mediterranean-Style Diet and Food in the Primary Prevention of Stroke”
  175. Importance of sex and gender in atherosclerosis and cardiovascular disease
  176. 3D carotid reconstructions: imaging, pathology, algorithms and pipelines
  177. Blood Pressure Control in Canada: The View From a Stroke Prevention Clinic
  178. Dilemmas in Diagnosing and Managing Hypertension: Is White Coat Hypertension Benign?
  179. Management of Asymptomatic Carotid Stenosis
  180. Statins and Cataracts: Reverse Causality?
  181. Recent advances in atrial fibrillation and stroke
  182. Aspirin for Prevention of Cardiovascular Events in Older Japanese Patients
  183. Letter by Spence Regarding Article, "Differential Effect of B-Vitamin Therapy by Antiplatelet Use on Risk of Recurrent Vascular Events After Stroke"
  184. Measurement of Carotid Plaque Burden
  185. Management of resistant hypertension
  186. Atrial Premature Beats Predict Atrial Fibrillation in Cryptogenic Stroke: Results From the EMBRACE Trial
  187. Are some diets "mass murder"? Mediterranean diet is not to blame for increased carbohydrate intake
  188. Statins and Intracerebral Hemorrhage
  189. The 99mTc-DTPA Urinary Clearance Method May Be Preferable to the Plasma Disappearance Method for Assessing Glomerular Filtration Rate in Diabetic Nephropathy
  190. Pioglitazone for secondary prevention after ischemic stroke and transient ischemic attack: Rationale and design of the Insulin Resistance Intervention after Stroke Trial
  191. Risk of Vascular Disease in Premenopausal Women With Diabetes Mellitus
  192. Identifying Which Patients With Asymptomatic Carotid Stenosis Could Benefit From Intervention: Table.
  193. Recurrent Stroke and Patent Foramen Ovale
  194. Cryptogenic Stroke and Atrial Fibrillation
  195. Secular Trends in Ischemic Stroke Subtypes and Stroke Risk Factors
  196. Statins and Ischemic Stroke
  197. How far to lower blood pressure in the long term, after a stroke?
  198. Time course of atherosclerosis regression
  199. Carnitine therapy for the treatment of metabolic syndrome and cardiovascular disease: Evidence and controversies
  200. Three-Dimensional Carotid Ultrasound Plaque Texture Predicts Vascular Events
  201. Arterial age as a substitute for chronological age in the AGLA risk function could improve coronary risk prediction
  202. Atrial Fibrillation in Patients with Cryptogenic Stroke
  203. Effects of homocysteine lowering with B vitamins on cognitive aging: meta-analysis of 11 trials with cognitive data on 22,000 individuals
  204. Pulmonary Abnormalities and Carotid Atherosclerosis in Ex-Smokers without Airflow Limitation
  205. A Single Fixed-Dose Combination for All Patients Is Bad Medicine
  206. Volume of Carotid Artery Ulceration as a Predictor of Cardiovascular Events
  207. Microhabitat Use in a Northern Peripheral Population ofApodemia mormo: Factors Beyond the Host Plant
  208. Free fatty acids to predict recurrent ischemic stroke
  209. Effects of the Intestinal Microbiome on Constituents of Red Meat and Egg Yolks: A New Window Opens on Nutrition and Cardiovascular Disease
  210. SPARKLE (Subtypes of Ischaemic Stroke Classification System), Incorporating Measurement of Carotid Plaque Burden: A New Validated Tool for the Classification of Ischemic Stroke Subtypes
  211. Carotid Stenosis
  212. Egg consumption and coronary disease: Letter to the editor regarding Chagas P, Caramori P, Galdino TP, Barcellos CS, Gomes I, Schwanke CH. Egg consumption and coronary atherosclerotic burden. Atherosclerosis 2013 August;229(2):381–4
  213. Trust between specialists and family physicians
  214. One, two and three-dimensional ultrasound measurements of carotid atherosclerosis before and after cardiac rehabilitation: preliminary results of a randomized controlled trial
  215. Intensive risk factor control in stroke prevention
  216. Retinal Vasculature: A Window on the Brain
  217. Barometer in the Storm—Carotid Artery Plaque Quantified by Three-Dimensional Ultrasound
  218. Treatment of Renal Artery Stenosis
  219. Progression of Carotid Plaque Volume Predicts Cardiovascular Events
  220. Closure of Patent Foramen Ovale versus Medical Therapy after Cryptogenic Stroke
  221. Why Calls for More Routine Carotid Stenting Are Currently Inappropriate: An International, Multispecialty, Expert Review and Position Statement
  222. Egg yolk consumption, smoking and carotid plaque: Reply to letters to the Editor by Sean Lucan and T Dylan Olver et al.
  223. Atherosclerosis Imaging and the Canadian Atherosclerosis Imaging Network
  224. Effects of folic acid supplementation on overall and site-specific cancer incidence during the randomised trials: meta-analyses of data on 50 000 individuals
  225. Migraine, Shear Stress, and Platelet Serotonin
  226. Diabetes, Intracranial Stenosis and Microemboli in Asymptomatic Carotid Stenosis
  227. Asymptomatic Carotid Stenosis
  228. Blood pressure and opera
  229. Ultrasonographic Measure of Carotid Plaque Burden
  230. B vitamin therapy for homocysteine: renal function and vitamin B12 determine cardiovascular outcomes
  231. Antihypertensive treatment can prevent stroke and cognitive decline
  232. Atrial fibrillation and stroke prevention: is warfarin still an option? Yes
  233. Effects of Aldosterone on Human Atherosclerosis: Plasma Aldosterone and Progression of Carotid Plaque
  234. Imaging atherosclerosis with hybrid [18F]fluorodeoxyglucose positron emission tomography/computed tomography imaging: What Leonardo da Vinci could not see
  235. Egg yolk consumption and carotid plaque
  236. Premature Atherosclerosis Is Associated With Hypovitaminosis D and Angiotensin-Converting Enzyme Inhibitor Non-use in Lupus Patients
  237. Letter to the Editor: The ezetimibe ‘controversy' is a misunderstanding
  238. Albuminuria and risk of stroke in African Americans: A marker of uncontrolled hypertension?
  239. Statins do not cause intracerebral hemorrhage
  240. Genetics of atherosclerosis: The power of plaque burden and progression
  241. Mechanisms of Lipoprotein(a) Pathogenicity: Prothrombotic, Proatherosclerotic, or Both?
  242. Antiplatelet therapy and the effects of B vitamins in patients with previous stroke or transient ischaemic attack: a post-hoc subanalysis of VITATOPS, a randomised, placebo-controlled trial
  243. Lessons From Africa: The Importance of Measuring Plasma Renin and Aldosterone in Resistant Hypertension
  244. Why the US Center for Medicare and Medicaid Services Should Not Extend Reimbursement Indications for Carotid Artery Angioplasty/Stenting
  245. Pseudohypertension
  246. Why the United States Center for Medicare and Medicaid Services (CMS) should not extend reimbursement indications for carotid artery angioplasty/stenting
  247. Why the United States Center for Medicare and Medicaid Services (CMS) Should not Extend Reimbursement Indications for Carotid Artery Angioplasty/Stenting
  248. Identifying high-risk asymptomatic carotid stenosis
  249. Why the United States Center for Medicare and Medicaid Services should not extend reimbursement indications for carotid artery angioplasty/stenting
  250. Ezetimibe and Regression of Carotid Atherosclerosis
  251. Carotid plaque measurement is superior to IMT
  252. Understanding the Complexity of Homocysteine Lowering With Vitamins
  253. High-risk asymptomatic carotid stenosis: Ulceration on 3D ultrasound vs TCD microemboli
  254. Short-acting nifedipine and risk of stroke
  255. New and Emerging Weight Management Strategies for Busy Ambulatory Settings: A Scientific Statement From the American Heart Association * Endorsed by the Society of Behavioral Medicine
  256. Asymptomatic Carotid Stenosis: Identifying Patients at High Enough Risk to Warrant Endarterectomy or Stenting
  257. Influence of Noninvasive Cardiovascular Imaging in Primary Prevention
  258. Reply to Letters from Dr Maria Luz Fernandez, Eddie Vos, and Dr Niva Shapira
  259. Toward Clinical Applications of Carotid Ultrasound: Intima-Media Thickness, Plaque Area, and Three-Dimensional Phenotypes
  260. Carotid Plaque Surface Irregularity
  261. Volumetric Evaluation of Carotid Atherosclerosis Using 3-Dimensional Ultrasonic Imaging
  262. Response to Letter by Hadjiev et al
  263. 3D Carotid Ultrasound Imaging
  264. Clinical Clues to Paradoxical Embolism
  265. Effects of Lowering Homocysteine Levels With B Vitamins on Cardiovascular Disease, Cancer, and Cause-Specific MortalityMeta-analysis of 8 Randomized Trials Involving 37 485 IndividualsEffects of Lowering Homocysteine Lev...
  266. Is there a role for revascularisation in asymptomatic carotid stenosis? No
  267. Is there a role for revascularisation in asymptomatic carotid stenosis? Yes
  268. B vitamins in patients with recent transient ischaemic attack or stroke in the VITAmins TO Prevent Stroke (VITATOPS) trial: a randomised, double-blind, parallel, placebo-controlled trial
  269. B-Vitamin Therapy for Diabetic Nephropathy—Reply
  270. Secondary stroke prevention
  271. Identifying high-risk patients from carotid plaque composition
  272. Asymptomatic Carotid Stenosis: Mainly a Medical Condition
  273. Physiologic Tailoring of Treatment in Resistant Hypertension
  274. Effect of B-Vitamin Therapy on Progression of Diabetic Nephropathy
  275. Treating Arteries Instead of Risk Factors: A Paradigm Change in Management of Atherosclerosis
  276. Extremes of Unexplained Variation as a Phenotype: An Efficient Approach for Genome-Wide Association Studies of Cardiovascular Disease
  277. Three-dimensional ultrasound-based texture analysis of the effect of atorvastatin on carotid atherosclerosis
  278. Dietary Intervention to Reverse Carotid Atherosclerosis
  279. The role of lipoprotein(a) in the formation of arterial plaques, stenoses and occlusions
  280. Improvement of cardiovascular risk prediction: time to review current knowledge, debates, and fundamentals on how to assess test characteristics
  281. Effects of Intensive Medical Therapy on Microemboli and Cardiovascular Risk in Asymptomatic Carotid Stenosis
  282. Three-Dimensional Carotid Ultrasound Segmentation Variability Dependence on Signal Difference and Boundary Orientation
  283. Three-dimensional Ultrasound Quantification of Intensive Statin Treatment of Carotid Atherosclerosis
  284. Treating Hypertension in Acute Ischemic Stroke
  285. Atrial fibrillation, stroke prevention therapy and aging
  286. Longitudinal Ultrasound Evaluation of Carotid Atherosclerosis in One, Two and Three Dimensions
  287. Mechanisms of thrombogenesis in atrial fibrillation
  288. Analysis of carotid lumen surface morphology using three-dimensional ultrasound imaging
  289. Nonrigid registration of three-dimensional ultrasound and magnetic resonance images of the carotid arteries
  290. Carotid Atherosclerosis and a Reduced Likelihood for Lowered Cognitive Performance in a Canadian First Nations Population
  291. Diagnosis of primary aldosteronism: for medical management, not just surgery
  292. Mesna for the Treatment of Hyperhomocysteinemia in Hemodialysis Patients
  293. Area-preserving flattening maps of 3D ultrasound carotid arteries images
  294. Cryptogenic stroke and patent foramen ovale: Clinical clues to paradoxical embolism
  295. Scan–rescan and intra-observer variability of magnetic resonance imaging of carotid atherosclerosis at 1.5 T and 3.0 T
  296. Is Carotid Intima-Media Thickness a Reliable Clinical Predictor?
  297. A “Twisting and Bending” Model-Based Nonrigid Image Registration Technique for 3-D Ultrasound Carotid Images
  298. Angiotensin inhibition in renovascular disease: A population-based cohort study
  299. The importance of distinguishing between diffuse carotid intima-media thickening and focal plaque
  300. Quantification of carotid vessel wall and plaque thickness change using 3D ultrasound images
  301. Lipoprotein(a) Is Associated Differentially With Carotid Stenosis, Occlusion, and Total Plaque Area
  302. Geometry of the Carotid Bifurcation Predicts Its Exposure to Disturbed Flow
  303. Intra-Arterial Thrombolysis of Occluded Middle Cerebral Artery by Use of Collateral Pathways in Patients with Tandem Cervical Carotid Artery/Middle Cerebral Artery Occlusion
  304. Cerebrovascular events on awakening, patent foramen ovale and obstructive sleep apnea syndrome
  305. Polypill: For Pollyanna*
  306. Mesna for Treatment of Hyperhomocysteinemia in Hemodialysis Patients: A Placebo-Controlled, Double-Blind, Randomized Trial
  307. White-Coat Hypertension Is Hypertension
  308. Nonrigid registration of carotid ultrasound and MR images using a "twisting and bending" model
  309. APPENDIX A: Carotid Endarterectomy-An Evidence-Based Review
  310. Mapping Spatial and Temporal Changes in Carotid Atherosclerosis from Three-Dimensional Ultrasound Images
  311. Role of Renin-Angiotensin System Blockade in Atherosclerotic Renal Artery Stenosis and Renovascular Hypertension
  312. Homocysteine-lowering therapy: a role in stroke prevention?
  313. Letter by Rundek et al Regarding Article, "Prediction of Clinical Cardiovascular Events With Carotid Intima-Media Thickness: A Systematic Review and Meta-Analysis"
  314. Mesna as a Nonvitamin Intervention to Lower Plasma Total Homocysteine Concentration: Implications for Assessment of the Homocysteine Theory of Atherosclerosis
  315. Stroke prevention in the high-risk patient
  316. Plasma total homocysteine in acute stroke
  317. SU-EE-A4-01: Development of Cardiac-Gated 3-Dimensional Ultrasound Imaging of Carotid Atherosclerosis
  318. Validation of 3D Ultrasound Vessel Wall Volume: An Imaging Phenotype of Carotid Atherosclerosis
  319. New treatment options for hypertension during acute ischemic or hemorrhagic stroke
  320. Combining Multiple Approaches for the Secondary Prevention of Vascular Events After Stroke: A Quantitative Modeling Study
  321. Manual planimetric measurement of carotid plaque volume using three-dimensional ultrasound imaging
  322. Effects of non-steroidal anti-inflammatory drugs on blood pressure
  323. Hypertension Due to Central Nervous System Dysfunction
  324. Intensive management of risk factors for accelerated atherosclerosis: the role of multiple interventions
  325. Perspective on the efficacy analysis of the Vitamin Intervention for Stroke Prevention trial
  326. The Effect of Mesna on Plasma Total Homocysteine Concentration in Hemodialysis Patients
  327. 3D ultrasound analysis of carotid plaque volume and surface morphology
  328. Carotid ultrasound phenotypes in vulnerable populations
  329. Homocysteine and Stroke Prevention: Have the Trials Settled the Issue?
  330. Measurement of Intima-Media Thickness vs. Carotid Plaque: Uses in Patient Care, Genetic Research and Evaluation of New Therapies
  331. Technology Insight: ultrasound measurement of carotid plaque—patient management, genetic research and therapy evaluation
  332. A Non-Rigid Image Registration Technique for 3D Ultrasound Carotid Images using a "Twisting and Bending" Model
  333. Measuring Effects of Antiatherosclerotic Therapies
  334. Quantification of progression and regression of carotid vessel atherosclerosis using 3D ultrasound images
  335. Thiol exchange: An in vitro assay that predicts the efficacy of novel homocysteine lowering therapies
  336. Nutrition and Stroke Prevention
  337. Relationship of the metabolic syndrome to carotid ultrasound traits
  338. Po-Thur Eve General-20: A Novel Non-Invasive 3D Ultrasound Imaging Phenotype of Carotid Atherosclerosis
  339. Po-Thur Eve General-24: Non-Invasive Imaging Phenotypes of Carotid Atherosclerosis in Subjects: MRI, B-mode and 3D Ultrasound Measurements
  340. Treating Hypertension in Acute Stroke: A Better Arrow for the Quiver
  341. Lipoprotein(a): Involved in Events, but Not Burden of Atherosclerotic Disease?
  342. Folate supplementation and cardiovascular disease
  343. Quantification of carotid vessel atherosclerosis
  344. Letter to the Editor: Individualized Therapy for Hypertension
  345. Homocysteine: Call Off the Funeral
  346. 3D Ultrasound System for Analysis of Carotid Plaque Progression and Regression
  347. Tutorial in Biostatistics: Analyzing Associations between Total Plasma Homocysteine and B Vitamins Using Optimal Categorization and Segmented Regression
  348. Disparate Associations of a Functional Promoter Polymorphism in PCK1 With Carotid Wall Ultrasound Traits
  349. Vitamin Intervention for Stroke Prevention Trial: An Efficacy Analysis
  350. Absence of Microemboli on Transcranial Doppler Identifies Low-Risk Patients With Asymptomatic Carotid Stenosis
  351. Variation in the Carotid Bifurcation Geometry of Young Versus Older Adults: Implications for Geometric Risk of Atherosclerosis
  352. Erratum to “Differences between carotid wall morphological phenotypes measured by ultrasound in one, two and three dimensions” [Atherosclerosis 178(2) (2005) 319–325]
  353. Carotid endarterectomy--An evidence-based review: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
  354. 3D Ultrasound Measurement of Change in Carotid Plaque Volume: A Tool for Rapid Evaluation of New Therapies
  355. Complications of Type 2 Diabetes Among Aboriginal Canadians: Prevalence and associated risk factors
  356. A comparison of ultrasound measurements to assess carotid atherosclerosis development in subjects with and without type 2 diabetes
  357. Vitamin B12, homocysteine and carotid plaque in the era of folic acid fortification of enriched cereal grain products
  358. Quantification of carotid plaque volume measurements using 3D ultrasound imaging
  359. Differences between carotid wall morphological phenotypes measured by ultrasound in one, two and three dimensions
  360. Anthropometric data for magnetic resonance imaging of the carotid bifurcation
  361. Carotid Ultrasound in One, Two and Three Dimensions
  362. Dimercaptosuccinic acid for the treatment of hyperhomocysteinemia in hemodialysis patients: A placebo-controlled, double-blind, randomized trial
  363. The current epidemic of primary aldosteronism
  364. Carotid intima-media thickness and cognitive decline: what does it mean for prevention of dementia?
  365. Genetic Variation in PPARG Encoding Peroxisome Proliferator-Activated Receptor   Associated With Carotid Atherosclerosis
  366. Non-Invasive Assessment of Atherosclerosis Risk
  367. 3D Ultrasound Imaging of the Carotid Arteries
  368. Preventing Dementia by Treating Hypertension and Preventing Stroke
  369. Single nucleotide polymorphism in CTH associated with variation in plasma homocysteine concentration
  370. Measurement of Carotid Plaque Volume by 3-Dimensional Ultrasound
  371. Noninvasive Phenotypes of Atherosclerosis: Similar Windows but Different Views
  372. Lowering Homocysteine in Patients With Ischemic Stroke to Prevent Recurrent Stroke, Myocardial Infarction, and Death
  373. Sex Differences in Carotid Plaque and Stenosis
  374. The Effect of Flax Seed Cultivars with Differing Content of α-Linolenic Acid and Lignans on Responses to Mental Stress
  375. Relationship Between Blood Pressure and Stroke Risk in Patients With Symptomatic Carotid Occlusive Disease
  376. Lipoprotein Lipase (LPL) Gene Variation and Progression of Carotid Artery Plaque
  377. Infection, Inflammation, and Atherosclerosis
  378. Measurement of Carotid Plaque and Effect of Vitamin Therapy for Total Homocysteine
  379. Carotid Plaque Area: A Tool for Targeting and Evaluating Vascular Preventive Therapy
  380. Treatment options for renovascular hypertension
  381. Grapefruit juice-drug interactions
  382. Reconstruction of carotid bifurcation hemodynamics and wall thickness using computational fluid dynamics and MRI
  383. Knowledge gaps
  384. Actual practice in hypertension: Implications for persistence with and effectiveness of therapy
  385. Endarterectomy or angioplasty for treatment of carotid stenosis?
  386. Homocyst(e)ine, nitrous oxide and atherosclerosis
  387. Improved Outcomes in Stroke Thrombolysis with Pre-specified Imaging Criteria
  388. Patients With Atherosclerotic Vascular Disease
  389. Vitamin Intervention for Stroke Prevention (VISP) Trial: Rationale and Design
  390. Effect of amlodipine on hemodynamic and endocrine responses to mental stress
  391. Angiotensin II antagonists for hypertension: are there differences in efficacy?
  392. Hypocholesterolemic effects of dietary citrus juices in rabbits
  393. Management of Resistant Hypertension in Patients with Carotid Stenosis: High Prevalence of Renovascular Hypertension
  394. What level of plasma homocyst(e)ine should be treated? Effects of vitamin therapy on progression of carotid atherosclerosis in patients with homocyst(e)ine levels above and below 14 μmol/L
  395. Pharmacokinetic-Pharmacodynamic Consequences and Clinical Relevance of Cytochrome P450 3A4 Inhibition
  396. Contents of Related Journals
  397. Serum metabolism of bradykinin and des-Arg9-bradykinin in patients with angiotensin-converting enzyme inhibitor-associated angioedema
  398. An approach to ascertain probands with a non-traditional risk factor for carotid atherosclerosis
  399. Low-dose and high-dose acetylsalicylic acid for patients undergoing carotid endarterectomy: a randomised controlled trial
  400. Effect of Usual Doses of Folate Supplementation on Elevated Plasma Homocyst(e)ine in Hemodialysis Patients: No Difference between 1 and 5 mg Daily
  401. Benefit of Carotid Endarterectomy in Patients with Symptomatic Moderate or Severe Stenosis
  402. Editorial commentary
  403. Carotid Endarterectomy Does Not Affect Long-Term Blood Pressure: Observations from the NASCET
  404. Clinical Pharmacokinetics of Fibric Acid Derivatives (Fibrates)
  405. Metabolism of Fibric Acid Derivatives
  406. Informing the public
  407. Pseudo-hypertension in the elderly: still hazy, after all these years
  408. Correspondence
  409. Grapefruit juice—terfenadine single-dose interaction: Magnitude, mechanism, and relevance*
  410. Psychological stress and the progression of carotid artery disease
  411. Erythromycin-felodipine interaction: Magnitude, mechanism, and comparison with grapefruit juice*
  412. The acetylcholinesterase oxime reactivator HI-6 in man: Pharmacokinetics and tolerability in combination with atropine
  413. Government guidelines for treatment of hypertension
  414. Prognosis for Patients Following a Transient Ischemic Attack With and Without a Cerebral Infarction on Brain CT
  415. Grapefruit Juice and Drugs
  416. Effect of grapefruit juice and naringin on nisoldipine pharmacokinetics
  417. Grapefruit juice–felodipine interaction: Mechanism, predictability, and effect of naringin
  418. Differences in metabolism of time-release and unmodified nicotinic acid: Explanation of the differences in hypolipidemic action?
  419. Tests for renal vascular disease
  420. Beneficial Effect of Carotid Endarterectomy in Symptomatic Patients with High-Grade Carotid Stenosis
  421. Interaction of citrus juices with felodipine and nifedipine
  422. Intramuscular administration of iron during long-term chelation therapy with 2,3-dimercaptosuccinic acid in a man with severe lead poisoning
  423. Measurement of Atherosclerosis: Development of an Atherosclerosis Severity Index
  424. EFFECT OF NON-STEROIDAL ANTI-INFLAMMATORY DRUGS ON CONTROL OF HYPERTENSION BY BETA-BLOCKERS AND DIURETICS
  425. Evaluation of once daily endralazine in hypertension
  426. The arthritic patient with hypertension: Selection of an NSAID
  427. Hypertension in Acute Ischemic Strokes
  428. EFFECTS OF TRIAMTERENE AND AMILORIDE ON URINARY SEDIMENT IN HYPERTENSIVE PATIENTS TAKING HYDROCHLOROTHIAZIDE
  429. Blood Pressure Measurement in the Elderly: Correlation of Arterial Stiffness with Difference Between Intra-arterial and Cuff Pressures
  430. Spectrum of benign intracranial hypertension in children and adolescents
  431. Hemodynamic modification of aortic atherosclerosis
  432. Potassium-sparing Diuretics: Interaction with Digoxin in Elderly Men
  433. Phenytoin-Theophylline Interaction
  434. Pseudohypertension in the Elderly
  435. Vitamins and antioxidants